We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.2B
AUM Growth
+$1.49B
Cap. Flow
-$841M
Cap. Flow %
-4.62%
Top 10 Hldgs %
18.93%
Holding
2,614
New
37
Increased
460
Reduced
567
Closed
1,419

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$87.4M
2
LRCX icon
Lam Research
LRCX
+$69.8M
3
V icon
Visa
V
+$62.2M
4
FISV
Fiserv Inc
FISV
+$55.7M
5
XLNX
Xilinx Inc
XLNX
+$41.2M

Sector Composition

Rank Sector Weight
1 Technology 23.75%
2 Healthcare 13.19%
3 Financials 11.7%
4 Consumer Discretionary 8.69%
5 Industrials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVW icon
351
iShares S&P 500 Growth ETF
IVW
$70.5B
$7.99M 0.04%
125,192
+15,892
+15% +$964K
ALL icon
352
Allstate
ALL
$70.6B
$7.93M 0.04%
72,109
-72,264
-50% -$7.1M
MLAB icon
353
Mesa Laboratories
MLAB
$551M
$7.65M 0.04%
26,704
+17,873
+202% +$4.92M
EFAV icon
354
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.35B
$7.62M 0.04%
103,804
-134,934
-57% -$9.51M
OTIS icon
355
Otis Worldwide
OTIS
$27.9B
$7.6M 0.04%
112,586
-46,089
-29% -$2.99M
MCHP icon
356
Microchip Technology
MCHP
$38.8B
$7.54M 0.04%
109,216
+2,104
+2% +$131K
LUV icon
357
Southwest Airlines
LUV
$21.7B
$7.49M 0.04%
160,788
+43,467
+37% +$1.88M
STC icon
358
Stewart Information Services
STC
$2.14B
$7.21M 0.04%
149,158
+148,866
+50,982% +$6.79M
PHM icon
359
Pultegroup
PHM
$25.2B
$7.12M 0.04%
165,211
+17,543
+12% +$777K
AZN icon
360
AstraZeneca
AZN
$269B
$7.11M 0.04%
71,095
+2,395
+3% +$254K
NVDA icon
361
NVIDIA
NVDA
$4.6T
$7M 0.04%
536,360
+7,600
+1% +$102K
GPC icon
362
Genuine Parts
GPC
$17.9B
$6.99M 0.04%
69,582
-4,825
-6% -$472K
EMN icon
363
Eastman Chemical
EMN
$7.69B
$6.95M 0.04%
69,291
+12,048
+21% +$1.12M
MTDR icon
364
Matador Resources
MTDR
$6.04B
$6.88M 0.04%
570,301
-46,573
-8% -$455K
HRL icon
365
Hormel Foods
HRL
$14.2B
$6.79M 0.04%
145,732
-24,021
-14% -$1.17M
C icon
366
Citigroup
C
$213B
$6.77M 0.04%
109,895
-511,912
-82% -$26M
IEFA icon
367
iShares Core MSCI EAFE ETF
IEFA
$186B
$6.67M 0.04%
96,577
+2,274
+2% +$147K
JAZZ icon
368
Jazz Pharmaceuticals
JAZZ
$16.1B
$6.63M 0.04%
40,200
+5,034
+14% +$750K
IWN icon
369
iShares Russell 2000 Value ETF
IWN
$14.3B
$6.63M 0.04%
50,347
-3,247
-6% -$383K
BDX icon
370
Becton Dickinson
BDX
$46.4B
$6.48M 0.04%
26,567
+75
+0.3% +$17.5K
ILMN icon
371
Illumina
ILMN
$29.5B
$6.43M 0.04%
17,877
+15,482
+646% +$4.94M
DUK icon
372
Duke Energy
DUK
$101B
$6.41M 0.04%
70,025
-6,946
-9% -$643K
EQIX icon
373
Equinix
EQIX
$99.4B
$6.41M 0.04%
8,979
-8,472
-49% -$6.31M
OGE icon
374
OGE Energy
OGE
$9.87B
$6.38M 0.04%
200,439
-12,338
-6% -$399K
VGT icon
375
Vanguard Information Technology ETF
VGT
$133B
$6.36M 0.04%
143,912
+2,464
+2% +$101K

Similar funds

Glenmede Trust's Q4 2020 Portfolio in Review

As of Q4 2020, Glenmede Trust held 2,614 positions worth $18.2B, up 9% from $16.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glenmede Trust withdrew a net $841M in Q4 2020, closing 1,419 positions and reducing 567 holdings. Its most notable exit was H&R Block, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in CryoPort worth $974K.

  • Glenmede Trust's largest Q4 2020 buy was CryoPort: 22,210 shares worth $974K.
  • Glenmede Trust added most to iShares Core S&P Small-Cap ETF in Q4 2020, an estimated $38.7M increase.
  • Glenmede Trust's biggest Q4 2020 reduction was Progressive, cutting an estimated $87.4M.
  • Glenmede Trust fully exited H&R Block in Q4 2020, selling an estimated $18.3M.
  • Glenmede Trust's ten largest holdings make up 19% of its $18.2B portfolio in Q4 2020.
  • Glenmede Trust opened 37 new positions and closed 1,419 in Q4 2020.
  • Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $18.2B.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.